Interim results of Charnley-Müller total hip arthroplasty.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001178:Arthroplasty; D003911:Dextrans / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006615:Hip / Q000601:surgery*; D006621:Hip Joint; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects; D008297:Male; D008722:Methods; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D026741:Physical Therapy Modalities; D011182:Postoperative Care; D011183:Postoperative Complications; D011446:Prospective Studies; D013530:Surgical Wound Infection / Q000209:etiology / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D003911:Dextrans